rdf:type |
|
lifeskim:mentions |
umls-concept:C0030705,
umls-concept:C0205179,
umls-concept:C0278502,
umls-concept:C0332257,
umls-concept:C0439841,
umls-concept:C0518214,
umls-concept:C0542559,
umls-concept:C1172402,
umls-concept:C1261322,
umls-concept:C1516634,
umls-concept:C1517927,
umls-concept:C1547135,
umls-concept:C1547139,
umls-concept:C1561560,
umls-concept:C1561561,
umls-concept:C2828372
|
pubmed:issue |
10
|
pubmed:dateCreated |
2003-10-30
|
pubmed:abstractText |
Forty-nine patients with locally advanced or recurrent gastric carcinoma were treated with a novel 5-FU derivatives, TS-1, in an ambulatory setting. The response rate and adverse effect as well as patients' QOL were evaluated.
|
pubmed:language |
jpn
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0385-0684
|
pubmed:author |
pubmed-author:HirabayashiNaokiN,
pubmed-author:HisamatuKazufumiK,
pubmed-author:KiriharaYoshimasaY,
pubmed-author:MukaidaHidenoriH,
pubmed-author:NagamineIchiroI,
pubmed-author:OedaMamoruM,
pubmed-author:OharaMasahiroM,
pubmed-author:OshitaAkikoA,
pubmed-author:SaekiSyujiS,
pubmed-author:SatouYukioY,
pubmed-author:TakiyamaWataruW
|
pubmed:issnType |
Print
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1453-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:14584277-Administration, Oral,
pubmed-meshheading:14584277-Adult,
pubmed-meshheading:14584277-Aged,
pubmed-meshheading:14584277-Ambulatory Care,
pubmed-meshheading:14584277-Antimetabolites, Antineoplastic,
pubmed-meshheading:14584277-Drug Administration Schedule,
pubmed-meshheading:14584277-Drug Combinations,
pubmed-meshheading:14584277-Female,
pubmed-meshheading:14584277-Humans,
pubmed-meshheading:14584277-Male,
pubmed-meshheading:14584277-Middle Aged,
pubmed-meshheading:14584277-Neoplasm Recurrence, Local,
pubmed-meshheading:14584277-Oxonic Acid,
pubmed-meshheading:14584277-Pyridines,
pubmed-meshheading:14584277-Quality of Life,
pubmed-meshheading:14584277-Stomach Neoplasms,
pubmed-meshheading:14584277-Survival Rate,
pubmed-meshheading:14584277-Tegafur
|
pubmed:year |
2003
|
pubmed:articleTitle |
[Clinical evaluation, including QOL of TS-1 for patients with locally advanced or recurrent gastric cancer at ambulatory setting].
|
pubmed:affiliation |
Dept. of Surgery, Hiroshima Asa Municipal Hospital.
|
pubmed:publicationType |
Journal Article,
English Abstract
|